Twelve
Funding History
| Series A · 07/2021 | $57M |
|---|---|
| Series B · 06/2022 | $130M |
| Series C · 09/2024 | $200M |
About
Twelve describes itself as the carbon transformation company: rather than treating CO2 solely as an emission to be captured and stored, its Opus electrochemical reactor uses renewable electricity to convert captured CO2 into the building-block chemicals used to make fuels, plastics and other materials historically derived from petroleum.
- founded
- 2015
- headquarters
- Berkeley, California
- totalDisclosedEquityFunding
- $387M
- employees
- 200+
Overview
Twelve was founded in 2015 by Stanford-trained engineers Dr. Kendra Kuhl, Dr. Etosha Cave and Nicholas Flanders, building on technology first developed under the name Obtainium (2014), then Opus 12, before the company rebranded as Twelve in June 2021.
The company's core technology, the Opus electrochemical reactor and its AirPlant Power-to-X platform, splits captured CO2 into carbon monoxide and other intermediates using renewable electricity, then converts those intermediates into finished fuels and chemicals such as E-Jet sustainable aviation fuel (SAF), E-Naphtha and eMade materials.
Twelve has partnered with corporations including Mercedes-Benz and Procter & Gamble on early CO2-derived material demonstrations, and with Microsoft and Alaska Airlines as anchor offtake and investment partners for its first commercial-scale facility, AirPlant One, in Moses Lake, Washington, which began producing on-spec E-Jet SAF in June 2026.
Private securities are speculative, illiquid, and involve risk of complete loss of principal. You should be prepared to hold private securities for an extended period; there is no assurance of a secondary market, an IPO, or other liquidity event. You are fully responsible for conducting your own due diligence. Pricing is indicative — nothing here is an offer of securities.